Abstract：
This study aims to elucidate the clinical efficacy of Mineral Trioxide Aggregate (MTA) and Bioceramic Materials in pulpotomy procedures for early-stage chronic pulpitis in deciduous teeth. The clinical data of 100 children with early chronic pulpitis in deciduous teeth treated at our institution between January 2021 and January 2023 were included retrospectively, which were divided into an experimental group (n = 50) and a control group (n = 50) according to the treatment methods. Experimental group received pulpotomy with Thera Cal LC as bioceramic pulp-capping material versus control group with MTA as pulp-capping agent. Comparative studies were conducted to assess the clinical effectiveness and differences between both pulp-capping techniques. At 12 months postoperatively, the experimental group showed a significantly higher success rate than the control group (96.00% vs. 80.00%, p < 0.05). Post-treatment inflammatory markers (Tumor Necrosis Factor-alpha (TNF-α), Interleukin-6 (IL-6) and Interleukin-8 (IL-8)) were substantially lower in the experimental group (p < 0.05). Furthermore, significantly lower pain scores and higher comfort and satisfaction scores were obtained in the experimental group (p < 0.05). Experimental group adverse reactions were also lower in the experimental group (p < 0.05). TheraCal LC bioceramic material treats early chronic pulpitis in deciduous teeth effectively. Clinically, it is an excellent therapeutic option for emergence of permanent dentition, pain relief, comfort and improvement of patient satisfaction.
摘要：
这项研究旨在阐明三氧化二矿聚集体（MTA）和生物陶瓷材料在乳牙早期慢性牙髓炎的牙髓切除术中的临床疗效。回顾性分析2021年1月至2023年1月间在我院治疗的100例乳牙早期慢性牙髓炎患儿的临床资料。根据治疗方法分为实验组(n=50)和对照组(n=50)。实验组采用TheraCalLC作为生物陶瓷盖髓材料进行牙髓切除术，对照组采用MTA作为盖髓剂。进行了比较研究，以评估两种盖髓技术之间的临床有效性和差异。术后12个月，实验组的成功率明显高于对照组(96.00%vs.80.00%,p<0.05)。治疗后炎症标志物(肿瘤坏死因子-α(TNF-α)，白细胞介素-6(IL-6)和白细胞介素-8(IL-8)在实验组中显著降低(p<0.05)。此外，试验组疼痛评分显著降低,舒适度和满意度评分较高(p<0.05)。实验组不良反应也低于实验组(p<0.05)。TheraCalLC生物陶瓷材料可有效治疗乳牙早期慢性牙髓炎。临床上,它是恒牙出现的一个很好的治疗选择，疼痛缓解,舒适度和提高患者满意度。
